International Brand Name:
In treatment of:
Symptomatic relief of Llergic conditions including Rhinitis and Chronic Urticaria;Angioedema,Conjunctivitis
Dizziness .Drowsiness. Fatigue, .Nervousness, .Sleepiness ,.Epigastric distress, .Dry mouth,.Nausea,.Vomiting, .Rash,Urine retention,Weight gain
Hypersensitivity to Cyproheptadine and other drugs of similar structure Angle closure glaucoma .Acute asthma .Peptic ulcer,. Bladder neck obstruction,. Prostatic hyperplasia. Pyloroduodenal obstruction..Debilitated patients .Patient on monoamine oxidase inhibitory therapy.
Hypertension. Hyperthyroidism,Increased intraocular pressure,Bronchial asthma,Patient should be cautioned against activities requiring mental alertness such as driving, operating machine or involving in any hazardous activities 6.Avoid alcohol
Alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, anti-anxiety drugs, narcotic analgesics): CNS depressant action potentiated. MAOIs, tricylic antidepressants and atropine: Antimuscarinic action potentiated.Aminoglycosides: Ototoxicity produced by aminoglycosides masked.
Adult: 12 - 16 mg / day in 3 - 4 divided doses. Maximum dose: 32 mg / day Migraine prophylaxis and vascular headaches: Initial dose: 4 mg and may be repeated after 30 minutes; A maintenance dose of 4 mg may be given every 4 to 6 hours. Children above 6 years: 8 - 12 mg / day in 2 - 3 divided doses Maximum dose: 16 mg / day Children 2 - 6: 4 - 6 mg / day in 2 - 3 divided doses Maximum dose: 12 mg / day